Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Black Diamond Therapeutics is a US-based biotechnology company specializing in the development of precision oncology therapies. Using its proprietary MAP platform, the company identifies targeted genetic mutations to develop innovative cancer treatments for patients with high unmet medical needs.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Black Diamond Therapeutics is scheduled to report its next quarterly earnings on 11/09/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Black Diamond Therapeutics last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -0.17 USD.
Black Diamond Therapeutics has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.